Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

P3 Health Partners (PIII) EBITDA Margin: 2019-2024

Historic EBITDA Margin for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to 21.21%.

  • P3 Health Partners' EBITDA Margin rose 167200.0% to 12.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.48%, marking a year-over-year decrease of 9400.0%. This contributed to the annual value of 21.21% for FY2024, which is 81300.0% down from last year.
  • Latest data reveals that P3 Health Partners reported EBITDA Margin of 21.21% as of FY2024, which was down 81300.0% from 13.08% recorded in FY2023.
  • P3 Health Partners' 5-year EBITDA Margin high stood at 5.82% for FY2020, and its period low was 148.5% during FY2022.
  • Its 5-year average for EBITDA Margin is 42.13%, with a median of 21.21% in 2024.
  • In the last 5 years, P3 Health Partners' EBITDA Margin skyrocketed by 1354300bps in 2023 and then tumbled by -81300bps in 2024.
  • Over the past 5 years, P3 Health Partners' EBITDA Margin (Annual) stood at 5.82% in 2020, then crashed by -279bps to 22.05% in 2021, then tumbled by -574bps to 148.5% in 2022, then soared by 91bps to 13.08% in 2023, then tumbled by -62bps to 21.21% in 2024.
  • Its EBITDA Margin was 21.21% in FY2024, compared to 13.08% in FY2023 and 148.5% in FY2022.